rs769996976

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_139058.3(ARX):​c.187G>A​(p.Ala63Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,209,363 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A63V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000088 ( 0 hom., 1 hem., cov: 24)
Exomes 𝑓: 0.0000027 ( 0 hom. 0 hem. )

Consequence

ARX
NM_139058.3 missense

Scores

1
2
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 1.69

Publications

0 publications found
Variant links:
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
ARX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: XL, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • intellectual disability, X-linked, with or without seizures, ARX-related
    Inheritance: XL Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
  • Partington syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked lissencephaly with abnormal genitalia
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • corpus callosum agenesis-abnormal genitalia syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile epileptic-dyskinetic encephalopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked spasticity-intellectual disability-epilepsy syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0959934).
BP6
Variant X-25015551-C-T is Benign according to our data. Variant chrX-25015551-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 581240.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARXNM_139058.3 linkc.187G>A p.Ala63Thr missense_variant Exon 1 of 5 ENST00000379044.5 NP_620689.1 Q96QS3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARXENST00000379044.5 linkc.187G>A p.Ala63Thr missense_variant Exon 1 of 5 1 NM_139058.3 ENSP00000368332.4 Q96QS3
ARXENST00000636609.1 linkn.*30G>A downstream_gene_variant 5
ARXENST00000637394.1 linkn.*62G>A downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00000885
AC:
1
AN:
113049
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000926
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000114
AC:
2
AN:
175835
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000369
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000229
GnomAD4 exome
AF:
0.00000274
AC:
3
AN:
1096314
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
361956
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26370
American (AMR)
AF:
0.0000570
AC:
2
AN:
35074
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19297
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30183
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53548
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4085
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
841331
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46018
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000885
AC:
1
AN:
113049
Hom.:
0
Cov.:
24
AF XY:
0.0000284
AC XY:
1
AN XY:
35167
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31169
American (AMR)
AF:
0.0000926
AC:
1
AN:
10800
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2652
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3595
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2737
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6254
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53400
Other (OTH)
AF:
0.00
AC:
0
AN:
1518
Alfa
AF:
0.0000868
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Oct 28, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 02, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

not specified Uncertain:1
Nov 07, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant Summary: The ARX c.187G>A (p.Ala63Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide and 3/4 in silico tools (SNPsandGO not captured here due to low reliability index) predict a "benign" outcome. However, these predictions have yet to be functionally assessed. The variant of interest has been observed in the large, broad control population, ExAC, with an allele frequency of 0.00003175 (2/62990), predominantly observed in the Latino population at a frequency of 0.0002661(2/7517, including 1 hemizygote). This frequency does not exceed the estimated maximum expected allele frequency for a pathogenic ARX variant of 0.00141. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories. Therefore, until additional information becomes available (ie, clinical and/or functional studies), the variant of interest has been classified as a "Variant of Uncertain Significance (VUS)." -

Corpus callosum agenesis-abnormal genitalia syndrome;C0796244:Intellectual disability, X-linked, with or without seizures, ARX-related;C0796250:Partington syndrome;C1846171:X-linked lissencephaly with abnormal genitalia;C3463992:Developmental and epileptic encephalopathy, 1 Uncertain:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Intellectual disability, X-linked, with or without seizures, ARX-related;C3463992:Developmental and epileptic encephalopathy, 1 Benign:1
Feb 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.16
T
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.69
T
M_CAP
Pathogenic
0.43
D
MetaRNN
Benign
0.096
T
MetaSVM
Benign
-0.74
T
MutationAssessor
Benign
0.79
N
PhyloP100
1.7
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.26
Sift
Benign
0.55
T
Sift4G
Benign
0.50
T
Polyphen
0.0030
B
Vest4
0.066
MutPred
0.054
Gain of phosphorylation at A63 (P = 0.0208);
MVP
0.79
MPC
1.1
ClinPred
0.13
T
GERP RS
3.1
PromoterAI
0.0055
Neutral
Varity_R
0.16
gMVP
0.29
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs769996976; hg19: chrX-25033668; API